238 related articles for article (PubMed ID: 36064671)
1. Enhancement of live vaccines by co-delivery of immune modulating proteins.
Manohar MM; Campbell BE; Walduck AK; Moore RJ
Vaccine; 2022 Sep; 40(40):5769-5780. PubMed ID: 36064671
[TBL] [Abstract][Full Text] [Related]
2. A protein-based subunit vaccine with biological adjuvants provides effective protection against Pasteurella multocida in pigs.
Wu MC; Wu HC; Lee JW; Chang WC; Chu CY
Vet Res; 2023 Mar; 54(1):17. PubMed ID: 36864537
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy afforded by live Pasteurella multocida vaccines in chickens is independent of lipopolysaccharide outer core structure.
Harper M; John M; Edmunds M; Wright A; Ford M; Turni C; Blackall PJ; Cox A; Adler B; Boyce JD
Vaccine; 2016 Mar; 34(14):1696-703. PubMed ID: 26892738
[TBL] [Abstract][Full Text] [Related]
4. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
Liao J; Gibson JA; Pickering BS; Watnick PI
mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
[TBL] [Abstract][Full Text] [Related]
5. Protection against fowl cholera in ducks immunized with a combination vaccine containing live attenuated duck enteritis virus and recombinant outer membrane protein H of
Apinda N; Nambooppha B; Rittipornlertrak A; Tankaew P; Punyapornwithaya V; Nair V; Sawada T; Sthitmatee N
Avian Pathol; 2020 Jun; 49(3):221-229. PubMed ID: 31899951
[TBL] [Abstract][Full Text] [Related]
6. A Novel Mucosal Adjuvant System for Immunization against Avian Coronavirus Causing Infectious Bronchitis.
Chandrasekar SS; Kingstad-Bakke B; Wu CW; Suresh M; Talaat AM
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669327
[TBL] [Abstract][Full Text] [Related]
7. Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines.
Moyle PM
Biotechnol Adv; 2017; 35(3):375-389. PubMed ID: 28288861
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague.
Kilgore PB; Sha J; Hendrix EK; Motin VL; Chopra AK
mBio; 2021 Dec; 12(6):e0322321. PubMed ID: 34872353
[TBL] [Abstract][Full Text] [Related]
9. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine.
Zuckermann FA; Martin S; Husmann RJ; Brandt J
Adv Vet Med; 1999; 41():447-61. PubMed ID: 9890035
[TBL] [Abstract][Full Text] [Related]
10. Pasteurella multocida inactivated with ferric chloride and adjuvanted with bacterial DNA is a potent and efficacious vaccine in Balb/c mice.
Homayoon M; Tahamtan Y; Kargar M; Hosseini SMH; Akhavan Sepahy A
J Med Microbiol; 2018 Sep; 67(9):1383-1390. PubMed ID: 30016232
[TBL] [Abstract][Full Text] [Related]
11. Modes of Action for Mucosal Vaccine Adjuvants.
Aoshi T
Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
[TBL] [Abstract][Full Text] [Related]
12. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
13. Mucosal immunity: implications for vaccine development.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Immunobiology; 1992 Feb; 184(2-3):157-79. PubMed ID: 1587541
[TBL] [Abstract][Full Text] [Related]
14. Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines.
Hartman AB; Van De Verg LL; Venkatesan MM
Infect Immun; 1999 Nov; 67(11):5841-7. PubMed ID: 10531238
[TBL] [Abstract][Full Text] [Related]
15. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
de Veer M; Meeusen E
Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
[TBL] [Abstract][Full Text] [Related]
16. Oxidized Carbon Nanosphere-Based Subunit Vaccine Delivery System Elicited Robust Th1 and Cytotoxic T Cell Responses.
Sawutdeechaikul P; Cia F; Bancroft G; Wanichwecharungruang S; Sittplangkoon C; Palaga T
J Microbiol Biotechnol; 2019 Mar; 29(3):489-499. PubMed ID: 30691253
[TBL] [Abstract][Full Text] [Related]
17. Improving vaccine performance with adjuvants.
Vogel FR
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S266-70. PubMed ID: 10875797
[TBL] [Abstract][Full Text] [Related]
18. Effect of different adjuvant formulations on the immunogenicity and protective effect of a live Mycoplasma hyopneumoniae vaccine after intramuscular inoculation.
Xiong Q; Wei Y; Xie H; Feng Z; Gan Y; Wang C; Liu M; Bai F; Xie F; Shao G
Vaccine; 2014 Jun; 32(27):3445-51. PubMed ID: 24731810
[TBL] [Abstract][Full Text] [Related]
19. Immune responses and protective efficacy of a novel DNA vaccine encoding outer membrane protein of avian Pasteurella multocida.
Gong Q; Qu N; Niu M; Qin C; Cheng M; Sun X; Zhang A
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):317-24. PubMed ID: 23340446
[TBL] [Abstract][Full Text] [Related]
20. Failure of oil adjuvants to enhance immunity induced in mice by an inactivated rabbit Pasteurella multocida vaccine.
Okerman L; Devriese LA
Vaccine; 1987 Dec; 5(4):315-8. PubMed ID: 3433919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
